Viewing Study NCT02102750


Ignite Creation Date: 2025-12-24 @ 5:25 PM
Ignite Modification Date: 2026-01-28 @ 8:16 PM
Study NCT ID: NCT02102750
Status: COMPLETED
Last Update Posted: 2017-10-10
First Post: 2014-03-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Pharmacokinetics of Tafluprost Ophthalmic Solution (0.0015%) in Pediatric Patients With Glaucoma or Ocular Hypertension
Sponsor: Santen Oy
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module